Category: Pharmaceuticals
Pharmaceuticals market research reports by Inkwood Research
-
Germany Cosmetic Bioactive Ingredients Market Forecast 2025-2032
Germany Cosmetic Bioactive Ingredients Market Forecast 2025-2032 The Germany cosmetic bioactive ingredients market is anticipated to rise at a CAGR of 5.33% from 2025 to 2032. Germany is one of the leading markets in the global cosmetic bioactive ingredients industry, with a strong consumer base tha ... Read More
-
Asia-pacific Cosmetic Bioactive Ingredients Market Forecast 2025-2032
Asia-pacific Cosmetic Bioactive Ingredients Market Forecast 2025-2032 The Asia-Pacific cosmetic bioactive ingredients market is expected to rise at a CAGR of 5.42% over the forecast period of 2025-2032. The base year considered for the study is 2024, and the estimated period is between 2025 and 2032 ... Read More
-
North America Cosmetic Bioactive Ingredients Market Forecast 2025-2032
North America Cosmetic Bioactive Ingredients Market Forecast 2025-2032 The North America cosmetic bioactive ingredients market is predicted to prosper at a CAGR of 5.11% over the forecast period of 2025-2032. The base year considered for the study is 2024, and the estimated period is between 2025 an ... Read More
-
Global Cosmetic Bioactive Ingredients Market Forecast 2025-2032
Global Cosmetic Bioactive Ingredients Market Forecast 2025-2032 The global cosmetic bioactive ingredients market is expected to record a CAGR of 5.29% during the forecast period 2025-2032. The base year considered for the study is 2024, and the estimated period is between 2025 and 2032. The market s ... Read More
-
Europe Cosmetic Bioactive Ingredients Market Forecast 2025-2032
Europe Cosmetic Bioactive Ingredients Market Forecast 2025-2032 The Europe cosmetic bioactive ingredients market is projected to grow at a CAGR of 5.19% over the forecast period of 2025-2032. The base year considered for the study is 2024, and the estimated period is between 2025 and 2032. MARKET IN ... Read More
-
United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The United States Alzheimer’s disease therapeutics & diagnostics market is expected to grow at a CAGR of 5.75% over the forecast period of 2024-2032. The market was valued at $2551.32 million in 2023 and is expect ... Read More
-
Global Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
Global Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The global Alzheimer’s disease therapeutics & diagnostics market was valued at $7366.84 million in 2023 and is expected to reach $12302.40 million by 2032, growing at a CAGR of 5.81% during the forecast period 2024-2032. ... Read More
-
Europe Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
Europe Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The Europe Alzheimer’s disease therapeutics & diagnostics market is projected to develop with a CAGR of 6.07% over the forecast period 2024-2032. The market was valued at $2105.39 million in 2023 and is expected to reach ... Read More
-
North America Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
North America Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The North America Alzheimer’s disease therapeutics & diagnostics market is estimated to develop with a CAGR of 5.60% over the forecast period 2024-2032. The market was valued at $2941.34 million in 2023 and is exp ... Read More
-
Asia-pacific Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
Asia-pacific Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032 The Asia-Pacific Alzheimer’s disease therapeutics & diagnostics market is expected to grow with a CAGR of 6.18% over the forecast period 2024-2032. The market was valued at $1686.32 million in 2023 and is expected ... Read More
-
Zilosul Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
Zilosul Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 ZILOSUL, also known as pentosan polysulfate sodium (PPS), is a semi-synthetic medication derived from the wood chips of European beech trees. The extraction process yields glucurono-xylans, which are then sulfated to crea ... Read More
-
X0002 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
X0002 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 X0002, also known as ibuprofenamine hydrochloride spray, is an innovative transdermal non-steroidal anti-inflammatory drug (NSAID) currently under clinical development for the treatment of osteoarthritis (OA) and rheumatoid ... Read More
-
Japan Dry Eye Disease Market Forecast 2024-2032
Japan Dry Eye Disease Market Forecast 2024-2032 The Japan dry eye disease market is projected to grow at a CAGR of 5.26% from 2024 to 2032. The market was valued at $251.44 million in 2023, reaching an expected revenue of $401.68 million by 2032. The rising prevalence of dry eye diseases in Japan is ... Read More
-
Asia-pacific Dry Eye Disease Market Forecast (2024-2032)
Asia-pacific Dry Eye Disease Market Forecast (2024-2032) The Asia-Pacific dry eye disease market is projected to grow at a CAGR of 5.51% during the forecast period from 2024 to 2032. The market was valued at $1216.91 million in 2023, reaching a revenue of $1987.33 million by 2032. MARKET INSIGHTS Fa ... Read More
-
Global Dry Eye Disease Market Forecast 2024-2032
Global Dry Eye Disease Market Forecast 2024-2032 As per Inkwood Research, the global dry eye disease market is expected to grow at a CAGR of 5.02% during the period from 2024 to 2032. The market was valued at $5673.53 million in 2023, reaching a revenue of $8884.34 million by 2032. Dry eye disease i ... Read More
-
Europe Dry Eye Disease Market Forecast 2024-2032
Europe Dry Eye Disease Market Forecast 2024-2032 The Europe dry eye disease market is projected to grow at a CAGR of 4.70% during the forecast period from 2024 to 2032. The market was valued at $1686.02 million in 2023, reaching a revenue of $2569.11 million by 2032. MARKET INSIGHTS The Europe dry e ... Read More
-
China Dry Eye Disease Market Forecast 2024-2032
China Dry Eye Disease Market Forecast 2024-2032 The China dry eye disease market is expected to grow at a CAGR of 5.81% from 2024 to 2032. The market was valued at $384.43 million in 2023, with projected revenue reaching $643.91 million by 2032. The market’s expansion is driven by a combination of f ... Read More
-
North America Dry Eye Disease Market Forecast 2024-2032
North America Dry Eye Disease Market Forecast 2024-2032 The North America dry eye disease market is expected to grow at a CAGR of 5.12% during the forecast period of 2024 to 2032. The market was valued at $2283.72 million in 2032, reaching a projected revenue of $3604.57 million by 2032. MARKET INSI ... Read More
-
Wegovy Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
Wegovy Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 WEGOVY (Semaglutide) is a synthetic version of the human glucagon-like peptide-1 (GLP-1) hormone. It promotes weight loss by decreasing appetite, enhancing feelings of fullness, reducing food consumption, and lowering calo ... Read More
-
United States Dry Eye Disease Market Forecast 2024-2032
United States Dry Eye Disease Market Forecast 2024-2032 The United States dry eye disease market is projected to grow at a CAGR of 5.09% from 2024 to 2032. The market was valued at $2103.11 by 2023, reaching a revenue of $3313.01 million by 2032. One of the primary drivers furling the country’s mark ... Read More
-
Tlc599 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
Tlc599 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 TLC599 is a proprietary formulation of dexamethasone sodium phosphate (DSP) utilizing the BioSeizer technology, designed to deliver up to 24 weeks of continuous pain relief. TLC599 offers the benefit of locally delivering ... Read More
-
Sprifermin Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
Sprifermin Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 Sprifermin (AS-902330) is a recombinant version of human fibroblast growth factor 18 (FGF18). Sprifermin acts as a strong agonist for FGFR2 and FGFR3 receptors. It is administered through injections directly into the j ... Read More
-
Rtx-grt7039 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
Rtx-grt7039 Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 RTX-GRT7039 (resiniferatoxin) is an investigational drug designed for pain relief in patients with knee osteoarthritis (OA). This highly potent agonist of the Transient Receptor Potential Vanilloid 1 (TRPV1) receptor ... Read More
-
Renu Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
Renu Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 ReNu is a cryopreserved amniotic suspension allograft (ASA) containing micronized amniotic membrane and amniotic fluid cells. The amniotic membrane serves a protective function, surrounding the fetus and acting as a barrier ... Read More
-
Mm-ii Osteoarthritis Drug Pipeline – Market Insights And Forecasts Up to 2032
Mm-ii Osteoarthritis Drug Pipeline – Market Insights And Forecasts Upto 2032 MM-II is a new non-opioid intra-articular injection designed to alleviate knee pain in patients with osteoarthritis. This treatment utilizes the unique characteristics of proprietary multilamellar liposomes alongside an inn ... Read More
Research Assistance
